Results 311 to 320 of about 3,725,361 (362)
Some of the next articles are maybe not open access.

Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies?

Trends in Biotechnology, 1992
Antibodies can now be rapidly isolated from large and diverse recombinant libraries by displaying functional antibody fragments on the surface of bacteriophage particles and directly selecting with antigen. This method has been used to isolate antibodies, including human antibodies, with and without immunization, and to improve the affinity and ...
John McCaffery, David J. Chiswell
openaire   +3 more sources

Antibodies in proteomics I: generating antibodies

Trends in Biotechnology, 2003
The explosion in genome sequencing, and in subsequent DNA array experiments, has provided extensive information on gene sequence, organization and expression. This has resulted in a desire to perform similarly broad experiments on all the proteins encoded by a genome.
BRADBURY A.   +9 more
openaire   +3 more sources

Biotinylation of Antibodies

1994
Using the characteristic of a high-affinity complex between avidin and biotin, biotinylated antibodies have wide applications in various immunochemical assays, especially where signal amplification is required. A method is described here for the biotinylation of immunoglobulins.
openaire   +5 more sources

Antibody and antibody derivatives as cancer therapeutics

WIREs Nanomedicine and Nanobiotechnology, 2019
Antibodies are an important class of therapeutic for treating a wide range of diseases. These versatile macromolecules can be engineered to target many different antigens and to utilize several mechanisms of action to produce a pharmacological effect. The most common antibody platform used for therapeutics is immunoglobulin G (IgG). Advances in protein‐
Keith J. Arlotta, Shawn C. Owen
openaire   +2 more sources

Antibodies in Vivo

Pharmacological Reviews, 1982
Of all classes of compounds, antibodies provide the greatest range of specificities and affinities. The number of interatomic interactions between an antibody combining site and a large ligand such as a receptor far exceeds those between the common small ligand or drug and its corresponding binding site.1 As a result, there is increased selectivity and
openaire   +3 more sources

Antiphospholipid antibodies and the antiphospholipid antibody syndrome

Drugs of Today, 2000
The antiphospholipid antibody syndrome is a multisystem disorder characterized by persistently elevated antiphospholipid antibodies and/or arterial or venous thrombosis, thrombocytopenia and recurrent spontaneous abortion. Anticardiolipin antibodies and the lupus anticoagulant are different classes of antiphospholipid antibodies associated with this ...
Jensen Sl, Nahass Gt
openaire   +3 more sources

Computational Analysis of Antibody Paratopes for Antibody Sequences in Antibody Libraries

2022
To ensure the functionalities of the antibodies in phage-displayed synthetic antibody libraries, we use computational method to evaluate the designs of the antibody libraries. The computational methodologies developed in our lab for designing antibody library provide rich information on the function of the designed antibody sequences-adequate antibody ...
Hung-Pin, Peng, An-Suei, Yang
openaire   +2 more sources

Antiphospholipid antibody and antiphospholipid antibody syndrome

Current Opinion in Rheumatology, 1991
New details have been added to the description of the antiphospholipid antibody syndrome. These include quantitation of risk of stroke; delineation of an associated acute occlusive vasculopathy syndrome, including its pathology; increased awareness of the association of adrenal insufficiency with antiphospholipid antibody; new demonstration of ...
openaire   +3 more sources

Catalytic Antibodies

Current Opinion in Chemical Biology, 1998
Following the end of the first decade in catalytic antibody research, recent efforts are reflecting a more introspective view of the field. Notably, X-ray crystal structure analyses of antibody catalysts are permitting an increased understanding of the evolution and modus operandi of these remarkable biocatalysts. Additionally, the breadth and scope of
P, Wentworth, K D, Janda
openaire   +2 more sources

Antibody structure and antibody engineering

Advanced Drug Delivery Reviews, 1988
Abstract Immunoglobulin (Ig) genes are efficiently expressed following transfection into myeloma cells. The heavy and light chain genes, cloned into two compatible plasmids with different selectible markers, can be delivered simultaneously into the same cell.
Lee K. Tan, Sherie L. Morrison
openaire   +2 more sources

Home - About - Disclaimer - Privacy